Farnaz Najmi Varzaneh
DownloadHi-Res Photo
About
Titles
Clinical Fellow
Appointments
Radiology & Biomedical Imaging
Clinical FellowPrimary
Other Departments & Organizations
Education & Training
- MD
- Tehran University of Medical Sciences
Research
Research at a Glance
Publications Timeline
A big-picture view of Farnaz Najmi Varzaneh's research output by year.
12Publications
122Citations
Publications
2020
Cancer Molecular and Functional Imaging
Najmi Varzaneh F, Baradaran Noveiry B. Cancer Molecular and Functional Imaging. 2020, 729-738. DOI: 10.1007/978-3-030-30845-2_31.Peer-Reviewed Original ResearchCitationsAltmetricConceptsMagnetic resonance imagingPET/CTMolecular imagingEffective therapyFunction of organsEffective treatmentImmune pathwaysMolecular imaging techniquesResonance imagingTumor cellsCT imagingFunctional imagingCancer molecularEarly stagesTumorsStem cellsFluorescence imagingImagingTumor detectionGenetic characteristicsPatient's bodyImaging techniquesCellsCancerous cellsAgent distribution
2018
Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival.
Pandey A, Pandey P, Aliyari Ghasabeh M, Najmi Varzaneh F, Shao N, Khoshpouri P, Zarghampour M, Fouladi D, Liddell R, Kamel I. Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival. Radiology 2018, 288: 109-117. PMID: 29584595, DOI: 10.1148/radiol.2018171593.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsViable tumor burdenViable tumor volumeUnresectable intrahepatic cholangiocarcinomaTransarterial chemoembolizationTumor burdenTumor volumeIntrahepatic cholangiocarcinomaOverall survivalKaplan-Meier survival analysisHigher overall survivalEvaluation of responsePrimary endpointHazard ratioMultivariable analysisUnderwent baselinePrognostic informationSurvival differencesVolumetric ADCMethods NinetyTumor metricsStudy durationSurvival analysisPatientsConclusions ChangesRECIST diameterAssociation of interferon regulatory factor 5 (IRF5) gene polymorphisms with juvenile idiopathic arthritis
Esmaeili Reykande S, Rezaei A, Sadr M, Shabani M, Najmi Varzaneh F, Ziaee V, Rezaei N. Association of interferon regulatory factor 5 (IRF5) gene polymorphisms with juvenile idiopathic arthritis. Clinical Rheumatology 2018, 37: 2661-2665. PMID: 29423720, DOI: 10.1007/s10067-018-4010-9.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsJuvenile idiopathic arthritisInterferon regulatory factor 5JIA groupIdiopathic arthritisDevelopment of JIAControl groupGene polymorphismsT alleleIRF5 single-nucleotide polymorphismsInterferon regulatory factor 5 (IRF5) gene polymorphismsIRF5 gene polymorphismsAuto-inflammatory syndromeImmune system activityRegulatory factor 5Inflammatory markersRisk factorsHealthy individualsG alleleIranian populationProtective factorsSystem activityTaqMan assaysSingle nucleotide polymorphismsGenotype frequenciesArthritisPrediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation
Najmi Varzaneh F, Pandey A, Aliyari Ghasabeh M, Shao N, Khoshpouri P, Pandey P, Zarghampour M, Fouladi D, Liddell R, Anders R, Kamel I. Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation. European Radiology 2018, 28: 3032-3040. PMID: 29383518, PMCID: PMC6435275, DOI: 10.1007/s00330-017-5198-9.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsPercentage tumor necrosisTumor necrosisLiver transplantHCC patientsTherapeutic decisionsLT groupMean percentage necrosisPost-TACE CTPost-treatment MRIImaging modalitiesFurther therapeutic decisionsPathological necrosisLipiodol retentionWhole cohortBaseline MRINecrosis biomarkersPathological correlationTumor responseHCC necrosisTarget lesionsHCC lesionsUnenhanced CTPercentage necrosisNecrosisDual imaging modalitiesFOXP3, RORγt and IL-10 cytokine profile in chronic heart failure.
Gorzin F, Amirzargar A, Mahmoudi M, Rahnemoon Z, Najmi Varzaneh F, Hedayat M, Sadati S, Eskandari V, Rahmati Z, Rezaei N. FOXP3, RORγt and IL-10 cytokine profile in chronic heart failure. Bratislava Medical Journal 2018, 118: 637-641. PMID: 29198133, DOI: 10.4149/bll_2017_122.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsChronic heart failureIL-10 protein expressionIL-10CHF patientsHeart failurePathophysiology of CHFAcid receptor-related orphan receptor γtReceptor-related orphan receptor γtRetinoic acid receptor-related orphan receptor γtProtein expressionAnti-inflammatory cytokinesNon-ischemic causesForkhead box P3Role of Foxp3Supernatants of PBMCsIL-10 proteinOrphan receptor γtTreg cellsCytokine profileBox P3Genes Foxp3Inflammatory processT cellsHealthy subjectsStudy population
2015
The Myth of Penicillin/Dexamethasone and Its Costs to the Health Care System of Iran.
Dadashi A, Jazayeri S, Shahlaee A, Najmi-Varzaneh F, Rahimi-Movaghar V. The Myth of Penicillin/Dexamethasone and Its Costs to the Health Care System of Iran. Iranian Journal Of Public Health 2015, 44: 726-7. PMID: 26284224, PMCID: PMC4537640.Peer-Reviewed Original ResearchAltmetric
2014
A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus.
Rostami P, Setoodeh A, Rabbani A, Nakhaei-Moghadam M, Najmi-Varzaneh F, Rezaei N. A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus. Iranian Journal Of Pediatrics 2014, 24: 173-8. PMID: 25535536, PMCID: PMC4268837.Peer-Reviewed Original ResearchCitationsConceptsInsulin glargineRegular insulinType 1 diabetes mellitusEnd of studySignificant differencesDaily NPHInsulin regimenMean HbA1cNPH insulinDiabetes mellitusGlycemic controlTotal cholesterolGroup of childrenConventional therapyBlood glucoseClinical trialsLipid profileAppropriate treatmentGlargineBeginning of studyAspartType 1Further complicationsInsulinMellitusEfficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis
Najmi Varzaneh F, Najmi Varzaneh F, Azimi A, Rezaei N, Sahraian M. Efficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis. Acta Neurologica Belgica 2014, 114: 273-278. PMID: 24604685, DOI: 10.1007/s13760-014-0286-y.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsExpanded Disability Status ScaleMultiple sclerosisAmbulatory indexEPO groupCase groupDouble-blind pilot studyRelapsing-remitting MS (RRMS) patientsRR-MS patientsDisability Status ScaleMagnetic resonance imaging (MRI) parametersMajor side effectsAnti-inflammatory agentsRole of erythropoietinBlack hole lesionsRR-MSSevere relapseClinical recoveryIntravenous erythropoietinMS patientsNeurodegenerative aspectsLarge trialsStatus ScaleCombination therapyRelapse phaseAvailable treatmentsInterleukin-23 receptor single nucleotide polymorphisms in ulcerative colitis. A study in Iranian populations
Ebrahimi Daryani N, Najmi Varzaneh F, Hedayat M, Taher M, Farhadi E, Mahmoudi M, Nicknam M, Bashashati M, Rezaei N. Interleukin-23 receptor single nucleotide polymorphisms in ulcerative colitis. A study in Iranian populations. Clinics And Research In Hepatology And Gastroenterology 2014, 38: 360-365. PMID: 24485526, DOI: 10.1016/j.clinre.2013.12.008.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsIL23R single-nucleotide polymorphismsReceptor single nucleotide polymorphismsUlcerative colitisGroup of patientsSingle nucleotide polymorphismsPatient groupIranian adult patientsDisease-modifying effectsFuture therapeutic interventionsReal-time polymerase chain reactionAdult patientsCrohn's diseasePolymerase chain reactionHealthy controlsNucleotide polymorphismsTT genotypeTherapeutic interventionsIranian populationPatientsT alleleSignificant associationGenetic factorsDiseaseChain reactionGenotype frequencies
2013
Liver Involvement in Iranian Children With Cystic Fibrosis: Ultrasonography and Biochemical Findings
Najafi M, Najmi Varzaneh F, Khatami G, Khodadad A, Fallahi G, Farahmand F, Motamed F, Mehdizadeh M, Alizadeh H, Rezaei N, Shoaran M. Liver Involvement in Iranian Children With Cystic Fibrosis: Ultrasonography and Biochemical Findings. Journal Of Comprehensive Pediatrics 2013, 4: 129-33. DOI: 10.17795/compreped-7304.Peer-Reviewed Original Research
Academic Achievements and Community Involvement
honor Certificate of Merit
National AwardAmerican Society of NeuroradiologyDetails12/01/2021United Stateshonor Research Award
National AwardNorth American Radiological SocietyDetails12/02/2020United Stateshonor Travel Award
National AwardRSNADetails12/19/2017United Stateshonor Travel Grant
International AwardESC 22nd, BerlinDetails12/14/2011Germany